A detailed further study is required to verify the interaction and crosstalk between the two TGF-β signaling pathways through Smad2/3 activation and Smad1/5/8 activation during EMT induction and metastasis of hepatoma cells. Here, SMAD2 is linked to hepatocellular carcinoma.